Key Drivers
- Strong cash flow
- High leverage
- Weak liquidity
AIAI Summary
IQVIA's strong cash generation and improving AI/commercial demand support upside, but the stock remains a balance-sheet repair story—investors should only get more constructive if management proves the earnings beat is durable and uses free cash flow to steadily reduce leverage, especially while the 157–163 support zone holds.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Strong cash flow
- •High leverage
- •Weak liquidity
IQV delivers solid profitability and strong cash flow conversion, but elevated leverage, weak short-term liquidity, and heavy intangible assets make the balance sheet the main risk.
Price Behavior
Key Price Behavior Insights:
- •Range rebound
- •Resistance stall
- •Support watch
IQV's short-term setup is mixed: it rebounded strongly from the late-April low but has since stalled near $178.7, leaving momentum dependent on holding the $157-$163 support band.
Sharp rebound from $156.66 to $178.71, then a pullback stalled near the highs
Sentiment & News
Key News Insights:
- •Q1 Beat
- •AI Demand
- •EPS Raised
IQVIA posted a Q1 beat, raised 2026 EPS guidance, and is seeing stronger AI-led demand and improving investor sentiment around its core data and clinical services.
The upbeat earnings and guidance raise reinforce a positive near-term outlook and strengthen the long-term growth case for the stock
Similar Companies in Healthcare
Other companies in the same sector with AI ratings